In COVID-19 clinical update #45, Daniel Griffin discusses J&J Ad26 vaccine results, reactogenicity after the second dose of mRNA vaccines, expansion of vaccine eligibility, and the finding that encephalitis after SARS-CoV-2 infection is a cytokine release syndrome.
Become a patron of TWiV!
Links for this episode
- J&J Ad26 vaccine phase 1/2 results (NEJM) 7:08
- SARS-CoV-2 encephalitis is a cytokine release syndrome (CID) 25:49
- Letters read on TWiV 707 30:26
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to email@example.com